Richard G IJzerman (Richard IJzerman)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Roux En Y Gastric Bypass

Combination Therapy

Top Venues

Diabetes, obesity & metabolism

The Journal of clinical endocrinology and metabolism

Journal of cachexia, sarcopenia and muscle

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Kristina S Fluitman, Mark Davids, Louise E Olofsson, Madelief Wijdeveld, Valentina Tremaroli, Bart J F Keijser, Marjolein Visser, Fredrik Bäckhed, Max Nieuwdorp, Richard G IJzerman
Gut microbial characteristics in poor appetite and undernutrition: a cohort of older adults and microbiota transfer in germ-free mice. Journal of cachexia, sarcopenia and muscle 13 (4) (2022)
Charlotte C van Ruiten, Dick J Veltman, Anouk Schrantee, Liselotte van Bloemendaal, Frederik Barkhof, Mark H H Kramer, Max Nieuwdorp, Richard G IJzerman
Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes. The Journal of clinical endocrinology and metabolism 107 (6) (2022)
Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman, Max Nieuwdorp, Klaas Hoogenberg, Daniel H van Raalte, Hiddo J Lambers Heerspink
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial. Diabetes, obesity & metabolism 23 (8) (2021)
Madelief Wijdeveld, Max Nieuwdorp, Richard G IJzerman
The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease. Expert opinion on therapeutic targets 24 (7) (2020)